EUVIMEDExplore EUVIMED
EUVIMED · CrossrefJournal

Cancer Medicine

ISSN 2045-7634 · Wiley

Latest articles

  1. Quality of Life Outcomes From the Phase 3 Study of Atezolizumab + Bevacizumab and Chemotherapy ( ATTLAS , KCSG ‐ LU19 ‐04) in EGFR / ALK ‐Mutated Non–Small‐Cell Lung Cancer

    Eun Joo Kang, Sehhoon Park, Tae Min Kim, Ji‐Youn Han, Gyeong‐Won Lee, Byoung Yong Shim, Yun‐Gyoo Lee, Sang‐We Kim, Il Hwan Kim, Suee Lee, Yu Jung Kim, Ji Hyun Park, Sang‐Gon Park, Ki Hyeong Lee, Ju Won Kim, Seong‐Hoon Shin, Chan‐Young Ock, Byung‐Ho Nam, Jaebong Lee, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn

    Published: 2026-11DOI: 10.1002/cam4.72405

Volumes

2026 · 9912025 · 9842024 · 1,1802023 · 1,8812022 · 4722021 · 8352020 · 9162019 · 7602018 · 6152017 · 2972016 · 3882015 · 2072014 · 1702013 · 1052012 · 42

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.